Capitolis Liquid Global Markets’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$139M Buy
567,301
+347,390
+158% +$80.9M 0.88% 21
2025
Q4
$45.5M Buy
219,911
+181,911
+479% +$36M 0.27% 78
2025
Q3
$7.05M Sell
38,000
-314,800
-89% -$53.9M 0.06% 160
2025
Q2
$53.9M Sell
352,800
-106,800
-23% -$16.4M 0.39% 51
2025
Q1
$76.2M Sell
459,600
-33,000
-7% -$5.16M 0.67% 31
2024
Q4
$71.2M Hold
492,600
0.69% 32
2024
Q3
$79.8M Buy
492,600
+362,800
+280% +$57.8M 0.85% 30
2024
Q2
$19M Sell
129,800
-500,000
-79% -$74.4M 0.23% 62
2024
Q1
$99.6M Buy
629,800
+129,800
+26% +$20.7M 1.6% 24
2023
Q4
$78.4M Buy
+500,000
New +$76.7M 3.22% 10

Other funds holding JNJ

Capitolis Liquid Global Markets's JNJ Position: Q1 2026 in Review

Capitolis Liquid Global Markets increased its Johnson & Johnson (JNJ) stake by 158% in Q1 2026, buying an estimated $80.9M and bringing the position to 567,301 shares worth $139M. The position accounts for 0.88% of the portfolio, ranked #21.

Capitolis Liquid Global Markets first reported a position in JNJ in Q4 2023 and has held it in 10 quarters since. 4,613 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Capitolis Liquid Global Markets held 567,301 shares of Johnson & Johnson worth $139M as of Q1 2026.
  • Capitolis Liquid Global Markets bought 347,390 Johnson & Johnson shares in Q1 2026, an estimated $80.9M.
  • Johnson & Johnson made up 0.88% of Capitolis Liquid Global Markets's portfolio in Q1 2026, its #21 holding.
  • Capitolis Liquid Global Markets first reported a position in Johnson & Johnson in Q4 2023 and has held it in 10 quarters since.
  • 4,613 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Capitolis Liquid Global Markets's 13F filing for Q1 2026, filed 15 May 2026.